• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群、功能性食品、动脉粥样硬化与血管钙化——存在缺失的环节吗?

Gut Microbiome, Functional Food, Atherosclerosis, and Vascular Calcifications-Is There a Missing Link?

作者信息

Cretoiu Dragos, Ionescu Ruxandra Florentina, Enache Robert Mihai, Cretoiu Sanda Maria, Voinea Silviu Cristian

机构信息

Department of Morphological Sciences, Cell and Molecular Biology and Histology, Carol Davila University of Medicine and Pharmacy, 8 Eroii Sanitari Blvd, 050474 Bucharest, Romania.

Alessandrescu-Rusescu National Institute for Mother and Child Health, Fetal Medicine Excellence Research Center, 020395 Bucharest, Romania.

出版信息

Microorganisms. 2021 Sep 9;9(9):1913. doi: 10.3390/microorganisms9091913.

DOI:10.3390/microorganisms9091913
PMID:34576810
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8472650/
Abstract

The gut microbiome is represented by the genome of all microorganisms (symbiotic, potential pathogens, or pathogens) residing in the intestine. These ecological communities are involved in almost all metabolic diseases and cardiovascular diseases are not excluded. Atherosclerosis, with a continuously increasing incidence in recent years, is the leading cause of coronary heart disease and stroke by plaque rupture and intraplaque hemorrhage. Vascular calcification, a process very much alike with osteogenesis, is considered to be a marker of advanced atherosclerosis. New evidence, suggesting the role of dietary intake influence on the diversity of the gut microbiome in the development of vascular calcifications, is highly debated. Gut microbiota can metabolize choline, phosphatidylcholine, and L-carnitine and produce vasculotoxic metabolites, such as trimethylamine-N-oxide (TMAO), a proatherogenic metabolite. This review article aims to discuss the latest research about how probiotics and the correction of diet is impacting the gut microbiota and its metabolites in the atherosclerotic process and vascular calcification. Further studies could create the premises for interventions in the microbiome as future primary tools in the prevention of atherosclerotic plaque and vascular calcifications.

摘要

肠道微生物群由存在于肠道中的所有微生物(共生菌、潜在病原体或病原体)的基因组所代表。这些生态群落几乎涉及所有代谢性疾病,心血管疾病也不例外。动脉粥样硬化近年来发病率持续上升,是冠心病和中风的主要原因,可导致斑块破裂和斑块内出血。血管钙化与骨生成非常相似,被认为是晚期动脉粥样硬化的一个标志。关于饮食摄入对肠道微生物群多样性在血管钙化发展中的影响作用的新证据,引发了激烈的争论。肠道微生物群可代谢胆碱、磷脂酰胆碱和左旋肉碱,并产生血管毒性代谢产物,如三甲胺-N-氧化物(TMAO),一种促动脉粥样硬化代谢产物。这篇综述文章旨在讨论关于益生菌和饮食调整如何影响肠道微生物群及其代谢产物在动脉粥样硬化过程和血管钙化中的最新研究。进一步的研究可为将微生物群干预作为预防动脉粥样硬化斑块和血管钙化的未来主要手段创造前提条件。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac11/8472650/63037ff20c50/microorganisms-09-01913-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac11/8472650/349372633ab9/microorganisms-09-01913-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac11/8472650/c327709fd73b/microorganisms-09-01913-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac11/8472650/e4426e0d5f84/microorganisms-09-01913-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac11/8472650/63037ff20c50/microorganisms-09-01913-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac11/8472650/349372633ab9/microorganisms-09-01913-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac11/8472650/c327709fd73b/microorganisms-09-01913-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac11/8472650/e4426e0d5f84/microorganisms-09-01913-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac11/8472650/63037ff20c50/microorganisms-09-01913-g004.jpg

相似文献

1
Gut Microbiome, Functional Food, Atherosclerosis, and Vascular Calcifications-Is There a Missing Link?肠道微生物群、功能性食品、动脉粥样硬化与血管钙化——存在缺失的环节吗?
Microorganisms. 2021 Sep 9;9(9):1913. doi: 10.3390/microorganisms9091913.
2
Amelioration of TMAO through probiotics and its potential role in atherosclerosis.通过益生菌改善 TMAO 及其在动脉粥样硬化中的潜在作用。
Appl Microbiol Biotechnol. 2019 Dec;103(23-24):9217-9228. doi: 10.1007/s00253-019-10142-4. Epub 2019 Oct 26.
3
Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.肠道微生物群组成可调节饮食中胆碱的生物利用度以及促动脉粥样硬化代谢物氧化三甲胺的积累。
mBio. 2015 Mar 17;6(2):e02481. doi: 10.1128/mBio.02481-14.
4
Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide.动脉粥样硬化中的肠道微生物群:聚焦三甲基胺 N-氧化物。
APMIS. 2020 May;128(5):353-366. doi: 10.1111/apm.13038. Epub 2020 Mar 30.
5
Can diet modulate trimethylamine N-oxide (TMAO) production? What do we know so far?饮食可以调节三甲胺 N-氧化物(TMAO)的产生吗?目前我们了解多少?
Eur J Nutr. 2021 Oct;60(7):3567-3584. doi: 10.1007/s00394-021-02491-6. Epub 2021 Feb 3.
6
Effect of Choline Forms and Gut Microbiota Composition on Trimethylamine--Oxide Response in Healthy Men.胆碱形式和肠道微生物组成对健康男性中三甲胺氧化物反应的影响。
Nutrients. 2020 Jul 25;12(8):2220. doi: 10.3390/nu12082220.
7
l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans.杂食饮食中的左旋肉碱在人体内诱导动脉粥样硬化的肠道微生物途径。
J Clin Invest. 2019 Jan 2;129(1):373-387. doi: 10.1172/JCI94601. Epub 2018 Dec 10.
8
Gut microbiota metabolism of L-carnitine and cardiovascular risk.肉碱的肠道微生物代谢与心血管风险。
Atherosclerosis. 2013 Dec;231(2):456-61. doi: 10.1016/j.atherosclerosis.2013.10.013. Epub 2013 Oct 24.
9
Gut microbiota-derived trimethylamine-N-oxide: A bridge between dietary fatty acid and cardiovascular disease?肠道微生物群衍生的氧化三甲胺:膳食脂肪酸与心血管疾病之间的桥梁?
Food Res Int. 2020 Dec;138(Pt B):109812. doi: 10.1016/j.foodres.2020.109812. Epub 2020 Oct 21.
10
Gut Microbiota and Atherosclerosis.肠道微生物群与动脉粥样硬化。
Curr Atheroscler Rep. 2017 Aug 25;19(10):39. doi: 10.1007/s11883-017-0675-9.

引用本文的文献

1
Association between single and multiple dietary vitamin exposure and heart failure risk: a cross-sectional study.单一及多种膳食维生素暴露与心力衰竭风险之间的关联:一项横断面研究。
J Thorac Dis. 2025 Jul 31;17(7):4746-4757. doi: 10.21037/jtd-2025-86. Epub 2025 Jul 29.
2
Intestinal Microbiota in Early Life: Latest Findings Regarding the Role of Probiotics as a Treatment Approach for Dysbiosis.早期生命中的肠道微生物群:关于益生菌作为失调治疗方法作用的最新发现
Nutrients. 2025 Jun 21;17(13):2071. doi: 10.3390/nu17132071.
3
New horizons in the treatment of psoriasis: Modulation of gut microbiome.

本文引用的文献

1
Interplay between gut microbiota, bone health and vascular calcification in chronic kidney disease.肠道微生物群、骨健康与慢性肾脏病血管钙化的相互作用。
Eur J Clin Invest. 2021 Sep;51(9):e13588. doi: 10.1111/eci.13588. Epub 2021 Jun 7.
2
Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome.小檗碱通过操纵肠道微生物组抑制三甲胺和氧化三甲胺的产生来减轻胆碱诱导的动脉粥样硬化。
NPJ Biofilms Microbiomes. 2021 Apr 16;7(1):36. doi: 10.1038/s41522-021-00205-8.
3
Extent of arterial calcification by conventional vitamin K antagonist treatment.
银屑病治疗的新视野:肠道微生物群的调节
Heliyon. 2025 Jan 3;11(1):e41672. doi: 10.1016/j.heliyon.2025.e41672. eCollection 2025 Jan 15.
4
Food to Prevent Vascular Calcification in Chronic Kidney Disease.预防慢性肾脏病血管钙化的食物。
Nutrients. 2024 Feb 23;16(5):617. doi: 10.3390/nu16050617.
5
Reactive Carbonyl Species and Protein Lipoxidation in Atherogenesis.动脉粥样硬化形成中的反应性羰基物种与蛋白质脂氧化
Antioxidants (Basel). 2024 Feb 14;13(2):232. doi: 10.3390/antiox13020232.
6
Adipokines and Bacterial Metabolites: A Pivotal Molecular Bridge Linking Obesity and Gut Microbiota Dysbiosis to Target.脂联素和细菌代谢产物:连接肥胖和肠道微生物失调与靶点的关键分子桥梁
Biomolecules. 2023 Nov 23;13(12):1692. doi: 10.3390/biom13121692.
7
The role of the gut microbiota in health and cardiovascular diseases.肠道微生物群在健康和心血管疾病中的作用。
Mol Biomed. 2022 Oct 11;3(1):30. doi: 10.1186/s43556-022-00091-2.
8
Association between trimethylamine N-oxide and prognosis of patients with acute myocardial infarction and heart failure.三甲基胺 N-氧化物与急性心肌梗死和心力衰竭患者预后的关系。
ESC Heart Fail. 2022 Dec;9(6):3846-3857. doi: 10.1002/ehf2.14009. Epub 2022 Jun 9.
9
The Interplay Between Gut Microbiota and miRNAs in Cardiovascular Diseases.肠道微生物群与微小RNA在心血管疾病中的相互作用
Front Cardiovasc Med. 2022 Mar 16;9:856901. doi: 10.3389/fcvm.2022.856901. eCollection 2022.
10
Intestinal Barrier and Permeability in Health, Obesity and NAFLD.健康、肥胖和非酒精性脂肪性肝病中的肠道屏障与通透性
Biomedicines. 2021 Dec 31;10(1):83. doi: 10.3390/biomedicines10010083.
常规维生素 K 拮抗剂治疗下的动脉钙化程度。
PLoS One. 2020 Oct 29;15(10):e0241450. doi: 10.1371/journal.pone.0241450. eCollection 2020.
4
Low-Carbohydrate Diet Score and Coronary Artery Calcium Progression: Results From the CARDIA Study.低碳水化合物饮食评分与冠状动脉钙进展:来自 CARDIA 研究的结果。
Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):491-500. doi: 10.1161/ATVBAHA.120.314838. Epub 2020 Oct 29.
5
The effects of probiotic/synbiotic supplementation compared to placebo on biomarkers of oxidative stress in adults: a systematic review and meta-analysis of randomized controlled trials.益生菌/合生制剂补充剂与安慰剂相比对成年人氧化应激生物标志物影响的系统评价和荟萃分析:随机对照试验。
Crit Rev Food Sci Nutr. 2022;62(2):490-507. doi: 10.1080/10408398.2020.1821166. Epub 2020 Oct 4.
6
Nutrition and Gastrointestinal Microbiota, Microbial-Derived Secondary Bile Acids, and Cardiovascular Disease.营养与胃肠道微生物群、微生物衍生次级胆汁酸与心血管疾病
Curr Atheroscler Rep. 2020 Jul 17;22(9):47. doi: 10.1007/s11883-020-00863-7.
7
Gustatory Function and the Uremic Toxin, Phosphate, Are Modulators of the Risk of Vascular Calcification among Patients with Chronic Kidney Disease: A Pilot Study.味觉功能和尿毒症毒素——磷酸盐——是慢性肾脏病患者血管钙化风险的调节剂:一项初步研究。
Toxins (Basel). 2020 Jun 25;12(6):420. doi: 10.3390/toxins12060420.
8
High-fat or high-sugar diets as trigger inflammation in the microbiota-gut-brain axis.高脂肪或高糖饮食会引发微生物群-肠道-大脑轴的炎症。
Crit Rev Food Sci Nutr. 2021;61(5):836-854. doi: 10.1080/10408398.2020.1747046. Epub 2020 Apr 8.
9
Indoxyl Sulfate, a Uremic Endotheliotoxin.硫酸吲哚酚,一种尿毒症内皮毒素。
Toxins (Basel). 2020 Apr 5;12(4):229. doi: 10.3390/toxins12040229.
10
The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions.肠道微生物组与冠状动脉疾病和心力衰竭:现有知识和未来方向。
EBioMedicine. 2020 Feb;52:102649. doi: 10.1016/j.ebiom.2020.102649. Epub 2020 Feb 12.